Mario Skugor, MD

Appointed
2002

Education & Fellowships

Fellowship - Cleveland Clinic
Endo, Diabetes and Metabolism
Cleveland, OH USA
2002

Residency - Saint Vincent Charity Medical Center
Internal Medicine
Cleveland, OH USA
2000

Residency - Saint Luke's Medical Center
Internal Medicine
Cleveland, OH USA
1999

Internship - Saint Luke's Medical Center
Internal Medicine
Cleveland, OH USA
1998

Medical School - University of Zagreb School of Medicine
Zagreb,
1986

Additional Training

• American Association of Clinical Endocrinologists
• American Thyroid Association
• Endocrine Society

Professional Highlights

• Co-Director, Endocrinology and Reproductive Organ Block, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, 2005-Present
• President, Ohio River Regional Chapter, American Association of Clinical Endocrinologists, 2007-2008
• Member, Task Force for Thyroid Ultrasound Testing and Certification, American Association of Clinical Endocrinologists, 2007-Present

Certifications

• Internal Medicine - Endocrinology, Diabetes and Metabolism

Specialty Interests

Hypothyroidism, hyperthyroidism, thyroid nodules, goiters, thyroid carcinoma, diabetes mellitus, hypercalcemia, hypocalcemia, osteoporosis, hyperlipidemia

Awards & Honors

• Skeletal assessment by FELS method, FELS Institute, Yellow Springs, Ohio, 1993
• Thyroid ultrasound and fine needle biopsy training course, Cleveland Clinic, 2001
   in teaching and training of medical students, residents and fellows.

Memberships

• Pfizer Scholars in Endocrinology Award, Oregon Health Sciences University
• Research findings selected by Program Directors at National Center for Research Resources to represent one of the most scientifically important advances published by investigators in 1997 and 1998

See publications for Mario Skugor, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 11/28/2018, Dr. Skugor has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.